Monday, July 16, 2012    |    |    Archives    |   Advertising   |    CHI Conferences    |     Subscribe      



DIA 2012 - Faster, Smarter, Easier (Part I)
eCliniqua | Correspondent Ann Neuer takes her annual pulse of e-clinical trends from the
vendor community exhibiting at the Drug Information Association (DIA) conference. In part 1
of a 2-part series, she profiles a few companies that stood out for me, including Greenphire,
Oracle, and a couple of start-ups in the Entrepreneur Pavilion. Read More

COMMENT: 2012 Survey Demonstrates Growth in eTMF and Impact of Standards
eCliniqua | In a Guest Commentary, Maryanne Quinn and Fran Ross discuss the results of a
new survey that indicates a significant growth in the number of organizations transitioning
to electronic Trial Master Files (eTMF).  Read More

Medidata, Tufts Study Leads News Roundup from DIA 2012
eCliniqua | Medidata Solutions, BBK Worldwide, ArisGlobal and iGate were among the e-clinical
companies making news at the annual gathering of the Drug Information Association (DIA) in
Philadelphia.  Read More


  ERT acquires Pittsburgh-based Invivodata
Pittsburgh Business Times | Invivodata Inc. has been acquired by technology company ERT,
making the latter it says the number one provider of clinical outcome assessments. Read More

How to Tell When A Drug Company Fibs About Clinical Trial Results
The Street | Reporter Adam Feuerstein diligently dissects an upbeat official announcement from
Osiris about its Prochymal heart attack study, parsing the language of clinical trial results while
finding independent sources of truthful information, such as  Read More

Voice Algorithms Spot Parkinson's disease
BBC News | British mathematician Max Little has developed a cheap, non-invasive test to
diagnose Parkinson's disease based on his discovery that symptoms can be detected by
computer algorithms that analyze voice recordings. He is now recruiting 10,000 volunteers to
have their voices recorded.  Read More

Glaxo Agrees to Pay $3 Billion in Fraud Settlement
New York Times | In the largest settlement involving a pharmaceutical company, the British
drugmaker GlaxoSmithKline has agreed to plead guilty to criminal charges and pay $3 billion in
fines for promoting its best-selling antidepressants for unapproved uses and failing to report
safety data about a top diabetes drug.  Read More

DIA: Drug, Food Safety Trumps Jobs, says FDA's Hamburg | Despite the global economic turmoil that has affected the drug industry, regulatory
leaders from North America and Europe, including FDA commissioner Margaret Hamburg, opened
the 2012 DIA convention saying that safety and science must not be compromised for the sake of
jobs that might be created if rules were relaxed.  Read More